SEC Form 4 · accession 0001562180-17-003867
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Aaron Lehman
Officer — General Counsel
Period of report
Dec 11, 2017
Accepted (ET)
Dec 13, 2017 · 7:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 11, 2017 | M | 36,000 | $18.00 | A | 45,000 | D | |
| Common StockF2 | Dec 11, 2017 | S | 36,000 | $32.75 | D | 9,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $18.00 | Dec 11, 2017 | M | 36,000 | D | — | Feb 21, 2026 | Common Stock | 36,000 | 94,000 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $33.00, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4.
- F3The vesting commencement date of the option is February 22, 2016. 25% of the shares subject to the option shall vest on February 22, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over three (3) years.